Radiation Therapy Oncology Group
Clinical trials sponsored by Radiation Therapy Oncology Group, explained in plain language.
-
Major trial seeks best combo to fight prostate cancer
Disease control CompletedThis large study aimed to find the best treatment for men with intermediate-risk prostate cancer. It compared standard high-dose radiation therapy alone against radiation combined with short-term hormone-blocking therapy. The goal was to see which approach helped patients live lo…
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Radiation combo vs. single treatment: which works best for prostate cancer?
Disease control CompletedThis study aimed to find the best radiation treatment for men with intermediate-risk prostate cancer. It compared a two-part treatment (external beam radiation plus internal seed implants) against using the seed implants alone. The goal was to see which approach better controlled…
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Extra chemo after surgery: can it stop cervical Cancer's return?
Disease control CompletedThis study tested whether adding extra chemotherapy after the standard combination of chemotherapy and radiation could better prevent cancer from returning in patients with high-risk cervical cancer who had already undergone surgery. It involved 236 women who were randomly assign…
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Major cancer trial tests gentler treatment for HPV-Linked throat cancer
Disease control CompletedThis large, completed study aimed to find the best way to treat throat cancer caused by the human papillomavirus (HPV). It compared the standard treatment of radiation plus a chemotherapy drug (cisplatin) against radiation plus a different, targeted drug (cetuximab). The main goa…
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Scientists test aggressive new combo to beat tough prostate cancer
Disease control CompletedThis study tested if adding a new hormone-blocking drug (TAK-700) to standard hormone therapy and radiation could better control high-risk prostate cancer. It involved 239 men and compared the new combination against the standard treatment. The main goals were to see if the stron…
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Radiation boost tested to fight tough liver cancer
Disease control CompletedThis study tested if adding a precise, high-dose radiation treatment (SBRT) to the standard drug sorafenib works better than using the drug alone for adults with advanced liver cancer. It involved 193 participants whose cancer was not suitable for surgery or other common treatmen…
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC